USC.edu
Are You a Patient?

Mark Agulnik, MD

Professor of Clinical Medicine

Vice Chair for Faculty Development, Department of Medicine

Section Chief of Sarcomas & Melanoma

Image of Mark Agulnik, MD
Is this your profile? Click to edit
Request an Appointment
Email [email protected]
CTSI Profile

Publications

  • Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives. Drug Des Devel Ther. 2016; 10:873-84.. View in PubMed
  • Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma. Am J Clin Oncol. 2015 Dec; 38(6):588-94.. View in PubMed
  • A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas. Oncologist. 2015 Nov; 20(11):1245-6.. View in PubMed
  • Targeted therapy and promising novel agents for the treatment of advanced soft tissue sarcomas. Expert Opin Investig Drugs. 2015; 24(11):1409-18.. View in PubMed
  • Targeted therapies in advanced differentiated thyroid cancer. Cancer Treat Rev. 2015 Sep; 41(8):690-8.. View in PubMed
  • Understanding rechallenge and resistance in the tyrosine kinase inhibitor era: imatinib in gastrointestinal stromal tumor. Am J Clin Oncol. 2014 Aug; 37(4):417-22.. View in PubMed
  • Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer. J Clin Oncol. 2014 Sep 01; 32(25):2735-43.. View in PubMed
  • Overview and management of dermatologic events associated with targeted therapies for medullary thyroid cancer. Thyroid. 2014 Sep; 24(9):1329-40.. View in PubMed
  • Occult primary, version 3.2014. J Natl Compr Canc Netw. 2014 Jul; 12(7):969-74.. View in PubMed
  • Examination of national lymph node evaluation practices for adult extremity soft tissue sarcoma. J Surg Oncol. 2014 Nov; 110(6):682-8.. View in PubMed

Similar People